{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:29:53Z","timestamp":1792002593840,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C19630\/A13265"],"award-info":[{"award-number":["C19630\/A13265"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001626","name":"Public Health Agency","doi-asserted-by":"publisher","award":["CDV\/4721\/12"],"award-info":[{"award-number":["CDV\/4721\/12"]}],"id":[{"id":"10.13039\/501100001626","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001590","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRA_HSR\/2012\/30"],"award-info":[{"award-number":["HRA_HSR\/2012\/30"]}],"id":[{"id":"10.13039\/501100001590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13058-016-0782-5","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T06:58:05Z","timestamp":1480575485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts"],"prefix":"10.1186","volume":"18","author":[{"given":"Chris R.","family":"Cardwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Potteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien","family":"Vaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Garmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam J.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline A. J.","family":"Vissers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O\u2019Rorke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kala","family":"Visvanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Cronin-Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlinde","family":"De Schutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Des G.","family":"Powe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrthe P. P.","family":"van Herk-Sukel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Friis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"782_CR1","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1517\/14656566.2010.482561","volume":"11","author":"WS Aronow","year":"2001","unstructured":"Aronow WS. Current role of beta-blockers in the treatment of hypertension. Expert Opin Pharmacopther. 2001;11:2599\u2013607.","journal-title":"Expert Opin Pharmacopther."},{"key":"782_CR2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1758834012439738","volume":"4","author":"TI Barron","year":"2012","unstructured":"Barron TI, Sharp L, Visvanathan K. Beta-adrenergic blocking drugs in breast cancer: a perspective review. Ther Adv Med Oncol. 2012;4:113\u201325.","journal-title":"Ther Adv Med Oncol."},{"key":"782_CR3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10549-011-1371-z","volume":"130","author":"DG Powe","year":"2011","unstructured":"Powe DG, Voss MJ, Habashy HO, et al. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study. Breast Cancer Res Treat. 2011;130:457\u201363.","journal-title":"Breast Cancer Res Treat."},{"key":"782_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ijc.20410","volume":"112","author":"K Lang","year":"2004","unstructured":"Lang K, Drell TL, Lindecke A, et al. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer. 2004;112:231\u20138.","journal-title":"Int J Cancer."},{"key":"782_CR5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.18632\/oncotarget.343","volume":"2","author":"E Pasquier","year":"2011","unstructured":"Pasquier E, Ciccolini J, Carre M, et al. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment. Oncotarget. 2011;2:797\u2013809.","journal-title":"Oncotarget."},{"key":"782_CR6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.phrs.2009.05.005","volume":"60","author":"B Annabi","year":"2009","unstructured":"Annabi B, Lachambre MP, Plouffe K, Moumdjian R, Beliveau R. Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacol Res. 2009;60:438\u201345.","journal-title":"Pharmacol Res."},{"key":"782_CR7","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1245\/s10434-008-9890-5","volume":"15","author":"M Benish","year":"2008","unstructured":"Benish M, Bartal I, Goldfarb Y, et al. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol. 2008;15:2042\u201352.","journal-title":"Ann Surg Oncol."},{"key":"782_CR8","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1158\/0008-5472.CAN-10-0522","volume":"70","author":"EK Sloan","year":"2010","unstructured":"Sloan EK, Priceman SJ, Cox BF, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70:7042\u201352.","journal-title":"Cancer Res."},{"key":"782_CR9","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1002\/ijc.21723","volume":"118","author":"D Palm","year":"2006","unstructured":"Palm D, Lang K, Niggemann B, et al. The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB\/c nude mice is inhibited by beta-blockers. Int J Cancer. 2006;118:2744\u20139.","journal-title":"Int J Cancer."},{"key":"782_CR10","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1080\/15384047.2015.1070988","volume":"16","author":"JM Wilson","year":"2015","unstructured":"Wilson JM, Lorimer E, Tyburski MD, Williams CL. Beta-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells. Cancer Biol Ther. 2015;16:1364\u201374.","journal-title":"Cancer Biol Ther."},{"key":"782_CR11","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/1078-0432.CCR-11-0641","volume":"18","author":"SW Cole","year":"2012","unstructured":"Cole SW, Sood AK. Molecular pathways: beta-adrenergic signaling in cancer. Clin Cancer Res. 2012;18:1201\u20136.","journal-title":"Clin Cancer Res."},{"key":"782_CR12","unstructured":"United States National Institutes of Health. Perioperative administration of COX 2 inhibitors and beta blockers to women undergoing breast cancer surgery. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00502684 . Accessed 15 Mar 2016."},{"key":"782_CR13","unstructured":"United States National Institutes of Health. Study of propranolol in newly diagnosed breast cancer patients undergoing neoadjuvant chemotherapy. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01847001 . Accessed 15 Mar 2016."},{"key":"782_CR14","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","volume":"29","author":"TI Barron","year":"2011","unstructured":"Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast cancer mortality: a population-based study. J Clin Oncol. 2011;29:2635\u201344.","journal-title":"J Clin Oncol."},{"key":"782_CR15","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/ije\/dyt196","volume":"42","author":"CR Cardwell","year":"2013","unstructured":"Cardwell CR, Coleman HG, Murray LJ, Entschladen F, Powe DG. Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort. Int J Epidemiol. 2013;42:1852\u201361.","journal-title":"Int J Epidemiol."},{"key":"782_CR16","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1200\/JCO.2012.43.9190","volume":"31","author":"GV Sorensen","year":"2013","unstructured":"Sorensen GV, Ganz PA, Cole SW, et al. Use of \u03b2-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study. J Clin Oncol. 2013;31:2265\u201372.","journal-title":"J Clin Oncol."},{"key":"782_CR17","unstructured":"European Cancer Pharmacoepidemiology Network. http:\/\/www.cancerpharmacoepi.eu . Accessed 15 Mar 2016."},{"issue":"7 Suppl","key":"782_CR18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"HW Kildemoes","year":"2011","unstructured":"Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7 Suppl):38\u201341.","journal-title":"Scand J Public Health"},{"key":"782_CR19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2174\/15680266113136660069","volume":"8","author":"PJ Peeters","year":"2013","unstructured":"Peeters PJ, Bazelier MT, Vestergaard P, et al. Use of metformin and survival of diabetic women with breast cancer. Curr Drug Saf. 2013;8:357\u201363.","journal-title":"Curr Drug Saf."},{"issue":"7 Suppl","key":"782_CR20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1403494810393562","volume":"39","author":"ML Gjerstorff","year":"2011","unstructured":"Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(7 Suppl):42\u20135.","journal-title":"Scand J Public Health"},{"issue":"3","key":"782_CR21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015;44(3):827\u201336.","journal-title":"Int J Epidemiol"},{"key":"782_CR22","volume-title":"PHARMO: a record linkage system for postmarketing surveillance of prescription drugs in the Netherlands","author":"R Herings","year":"1993","unstructured":"Herings R. PHARMO: a record linkage system for postmarketing surveillance of prescription drugs in the Netherlands. Utrecht: Utrecht University; 1993."},{"issue":"2","key":"782_CR23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejca.2009.09.010","volume":"46","author":"MP Herk-Sukel van","year":"2010","unstructured":"van Herk-Sukel MP, van de Poll-Franse LV, Lemmens VE, et al. New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System. Eur J Cancer. 2010;46(2):395\u2013404.","journal-title":"Eur J Cancer"},{"issue":"2","key":"782_CR24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/jgs.12101","volume":"61","author":"A Maguire","year":"2013","unstructured":"Maguire A, Hughes C, Cardwell C, O\u2019Reilly D. Psychotropic medications and the transition into care: a national data linkage study. J Am Geriatr Soc. 2013;61(2):215\u201321.","journal-title":"J Am Geriatr Soc"},{"key":"782_CR25","volume-title":"Quality indicators for the management of upper gastrointestinal cancer. Good clinical practice. KCE Reports 200. D\/2013\/10.273\/15","author":"J Vlayen","year":"2013","unstructured":"Vlayen J, De Gendt C, Stordeur S, et al. Quality indicators for the management of upper gastrointestinal cancer. Good clinical practice. KCE Reports 200. D\/2013\/10.273\/15. Brussels: Belgian Health Care Knowledge Centre (KCE); 2013."},{"issue":"7","key":"782_CR26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/pds.640","volume":"10","author":"D Williams","year":"2001","unstructured":"Williams D, Feely J. Pharmacoepidemiology\u2014an Irish perspective. Pharmacoepidemiol Drug Saf. 2001;10(7):641\u20135.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"782_CR27","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ije\/dyw060","volume":"45","author":"S Alvarez-Madrazo","year":"2016","unstructured":"Alvarez-Madrazo S, McTaggart S, Nangle C, Nicholson E, Bennie M. Data resource profile: the Scottish National Prescribing Information System (PIS). Int J Epidemiol. 2016;45(3):714\u20135f.","journal-title":"Int J Epidemiol"},{"key":"782_CR28","unstructured":"Socialstyrelsen. National Board of Health and Welfare: The Prescribed Drug Register [in Swedish]. http:\/\/www.nepi.net\/Socialstyrelsens-laekemedelsregister.htm . Accessed 15 Mar 2016."},{"issue":"7","key":"782_CR29","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, et al. The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726\u201335.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"782_CR30","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","volume":"28","author":"MD Holmes","year":"2010","unstructured":"Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin intake and survival after breast cancer. J Clin Oncol. 2010;28:1467\u201372.","journal-title":"J Clin Oncol."},{"key":"782_CR31","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/jnci\/djr291","volume":"103","author":"TP Ahern","year":"2011","unstructured":"Ahern TP, Pedersen L, Tarp M, et al. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst. 2011;103:1461\u20138.","journal-title":"J Natl Cancer Inst."},{"key":"782_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2296-11-1","volume":"11","author":"NF Khan","year":"2010","unstructured":"Khan NF, Perera R, Harper S, Rose PW. Adaptation and validation of the Charlson Index for Read\/OXMIS coded databases. BMC Fam Pract. 2010;11:1.","journal-title":"BMC Fam Pract."},{"key":"782_CR33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00005650-200301000-00011","volume":"41","author":"PA Fishman","year":"2003","unstructured":"Fishman PA, Goodman MJ, Hornbrook MC, et al. Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Med Care. 2003;41:84\u201399.","journal-title":"Med Care."},{"key":"782_CR34","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/sim.852","volume":"20","author":"TA Stukel","year":"2001","unstructured":"Stukel TA, Demidenko E, Dykes J, Karagas MR. Two-stage methods for the analysis of pooled data. Stat Med. 2001;20:2115\u201330.","journal-title":"Stat Med."},{"key":"782_CR35","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","volume":"340","author":"LE Levesque","year":"2010","unstructured":"Levesque LE, Hanley JA, Kezouh A, Suissa S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ. 2010;340:b5087.","journal-title":"BMJ."},{"key":"782_CR36","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/jnci\/djt211","volume":"105","author":"J Chubak","year":"2013","unstructured":"Chubak J, Boudreau DM, Wirtz HS, McKnight B, Weiss NS. Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survival. J Natl Cancer Inst. 2013;105:1456\u201362.","journal-title":"J Natl Cancer Inst."},{"key":"782_CR37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R Dersimonian","year":"1986","unstructured":"Dersimonian R, Laird N. Meta-analysis in clinical-trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials."},{"key":"782_CR38","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ."},{"key":"782_CR39","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/aje\/kwi307","volume":"162","author":"Z Zhou","year":"2005","unstructured":"Zhou Z, Rahme E, Abrahamowicz M, Pilote L. Survival bias associated with time-to-treatment initiation in drug effectiveness evaluation: a comparison of methods. Am J Epidemiol. 2005;162:1016\u201323.","journal-title":"Am J Epidemiol."},{"key":"782_CR40","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ije\/dyp392","volume":"39","author":"D Sarfati","year":"2010","unstructured":"Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol. 2010;39:598\u2013610.","journal-title":"Int J Epidemiol."},{"issue":"10","key":"782_CR41","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/annonc\/mdu042","volume":"25","author":"DS Chan","year":"2014","unstructured":"Chan DS, Vieira AR, Aune D, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901\u201314.","journal-title":"Ann Oncol"},{"issue":"7 Suppl","key":"782_CR42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1403494811399956","volume":"39","author":"LC Thygesen","year":"2001","unstructured":"Thygesen LC, Daasnes C, Thaulow I, Bronnum-Hansen H. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health. 2001;39(7 Suppl):12\u20136.","journal-title":"Scand J Public Health"},{"key":"782_CR43","unstructured":"Belgian law Gazette of 22-12-2006: http:\/\/www.kankerregister.org\/media\/docs\/Wetgeving\/Staatsbladgezondheidswet13122006pub22122006.pdf . Accessed 15 Mar 2016."}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-016-0782-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:59:11Z","timestamp":1498352351000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-016-0782-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1186\/s13058-016-0782-5","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12]]},"article-number":"119"}}